Beyaz FDA Approval History
FDA Approved: Yes (First approved September 24, 2010)
Brand name: Beyaz
Generic name: drospirenone, ethinyl estradiol and levomefolate calcium
Dosage form: Tablets
Company: Bayer HealthCare Pharmaceuticals Inc.
Treatment for: Birth Control, Premenstrual Dysphoric Disorder, Acne
Beyaz (drospirenone, ethinyl estradiol and levomefolate calcium) is an estrogen/progestin combined oral contraceptive containing a folate, indicated for use by women to prevent pregnancy, treat symptoms of premenstrual dysphoric disorder, treat moderate acne and to raise folate levels in women who choose to use an oral contraceptive for contraception.
Development timeline for Beyaz
| Date | Article |
|---|---|
| Sep 27, 2010 | Approval FDA Approves Beyaz - Combination Contraceptive Containing a Folate |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
